The Pesky Toad

The Toad's Take: Tech, Macro, & Pescadero Life

Reality Check Toad's Satire Survival Guide Community Hub Reading Stack Back to The Take

This story has rotated off the live feed but the permalink stays available for sharing and search.

news Scmp World 2026-04-09

Chinese Biotech Sector Secures $250M Deal in Asia-Pacific Acquisition

China's biopharmaceutical sector is experiencing increased investment, with funds from Singapore and the UAE supporting state-backed Chinese investors. Shanghai's Everest Medicines acquired rights to 14 chronic-disease treatments in the Asia-Pacific region.

Read Original Story →

Share on Facebook WhatsApp

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.